Exelixis to Release Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
Exelixis (NASDAQ: EXEL) has announced it will release its fourth quarter and full year 2024 financial results on Tuesday, February 11, 2025, after market close. The company's management will host a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results and provide a business update.
Investors can access the conference call by registering through a provided link, which will generate a unique PIN and dial-in number. The webcast will be available on the company's website under the Investors & News section's Event Calendar page, with a replay accessible for one year.
Exelixis (NASDAQ: EXEL) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'anno intero 2024 martedì 11 febbraio 2025, dopo la chiusura del mercato. Il management dell'azienda ospiterà una conferenza telefonica e un webcast alle 17:00 ET / 14:00 PT per discutere i risultati e fornire aggiornamenti aziendali.
Gli investitori possono accedere alla conferenza telefonica registrandosi tramite un link fornito, che genererà un PIN unico e un numero di accesso. Il webcast sarà disponibile sul sito web dell'azienda nella sezione Investitori & News, pagina del Calendario Eventi, con una registrazione accessibile per un anno.
Exelixis (NASDAQ: EXEL) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 el martes 11 de febrero de 2025, después del cierre del mercado. La dirección de la empresa realizará una llamada de conferencia y webcast a las 5:00 p.m. ET / 2:00 p.m. PT para discutir los resultados y proporcionar una actualización del negocio.
Los inversores pueden acceder a la llamada de conferencia registrándose a través de un enlace proporcionado, que generará un PIN único y un número de marcado. El webcast estará disponible en el sitio web de la empresa en la sección de Inversores y Noticias, página del Calendario de Eventos, con una repetición accesible durante un año.
Exelixis (NASDAQ: EXEL)는 2024년 4분기 및 연간 재무 결과를 2025년 2월 11일 화요일 시장 마감 후 발표할 것이라고 발표했습니다. 회사 경영진은 오후 5시 ET / 오후 2시 PT에 결과를 논의하고 비즈니스 업데이트를 제공하기 위한 전화 회의 및 웨비나를 개최합니다.
투자자들은 제공된 링크를 통해 등록하여 고유한 PIN 및 전화 접속 번호를 생성함으로써 전화 회의에 접근할 수 있습니다. 웨비나는 회사 웹사이트의 '투자자 및 뉴스' 섹션의 이벤트 캘린더 페이지에서 확인할 수 있으며, 1년 동안 다시 볼 수 있습니다.
Exelixis (NASDAQ: EXEL) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 le mardi 11 février 2025, après la clôture des marchés. La direction de l'entreprise animera une conférence téléphonique et un webinaire à 17h00 ET / 14h00 PT pour discuter des résultats et fournir une mise à jour de l'activité.
Les investisseurs peuvent accéder à la conférence téléphonique en s'inscrivant via un lien fourni, qui générera un code PIN unique et un numéro de composition. Le webinaire sera disponible sur le site Web de l'entreprise dans la section Investisseurs & Actualités, sur la page du calendrier des événements, avec un replay accessible pendant un an.
Exelixis (NASDAQ: EXEL) hat angekündigt, dass es am Dienstag, dem 11. Februar 2025, nach Börsenschluss seine Finanzergebnisse des vierten Quartals und des gesamten Jahres 2024 veröffentlichen wird. Das Management des Unternehmens wird um 17:00 Uhr ET / 14:00 Uhr PT eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen und ein Business-Update zu geben.
Investoren können sich über einen bereitgestellten Link zur Telefonkonferenz anmelden, der eine einzigartige PIN und eine Einwahlnummer generiert. Der Webcast wird auf der Unternehmenswebsite im Bereich Investoren & News unter der Seite Eventkalender verfügbar sein, mit einer Wiederholung, die ein Jahr lang zugänglich ist.
- None.
- None.
– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT –
To access the conference call, please register using this link. Upon registration, a dial-in number and unique PIN will be provided to join the call. To access the live webcast link, log onto www.exelixis.com and proceed to the Event Calendar page under the Investors & News heading. A webcast replay of the conference call will also be archived on www.exelixis.com for one year.
About Exelixis
Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody-drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX® (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com, follow @ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn.
Exelixis, the Exelixis logo and CABOMETYX are registered
View source version on businesswire.com: https://www.businesswire.com/news/home/20250128340505/en/
Investors Contact:
Varant Shirvanian
Director, Investor Relations
Exelixis, Inc.
650-837-7917
vshirvanian@exelixis.com
Media Contact:
Hal Mackins
For Exelixis, Inc.
415-994-0040
hal@torchcommunications.com
Source: Exelixis, Inc.
FAQ
When will Exelixis (EXEL) release Q4 and full year 2024 earnings?
What time is the Exelixis (EXEL) Q4 2024 earnings call?
How can investors access Exelixis (EXEL) Q4 2024 earnings call?
How long will Exelixis (EXEL) Q4 2024 earnings webcast be available?
